Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1994-10-25
1996-04-09
Parr, Margaret
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303888, 53038885, 5303879, 5303911, 5303913, 435 71, 435 723, C07K 1630, C07K 1646, A61K 39395, A61K 3944
Patent
active
055063438
ABSTRACT:
A monoclonal antibody which binds preferentially to unglycosylated DF3 antigen, compared to mature DF3 antigen, and which is specific for an epitope within the following amino acid sequence: T.sub.7 R.sub.8 P.sub.9 A.sub.10 P.sub.11 G.sub.12 S.sub.13, which epitope includes a proline at position 11.
REFERENCES:
patent: 4675382 (1987-06-01), Murphy
patent: 4894227 (1990-01-01), Stevens et al.
patent: 4963484 (1990-10-01), Kufe
patent: 5053489 (1991-10-01), Kufe
Waldmann Science 252:1657-1662 (1991).
Hopp: J. Immunol. Methods 88:1-18 (1986).
Harlow & Lane: Antibodies, A Lab Manual, Cold Spring Harbor, 1988.
Houghton et al. Seminars in Oncology 13:165-179 (1986).
Gendler et al. J. Biol Chem. 263:12820-12823 (1988).
Abe et al. Biochem. & Biophys. Res. Commun. 165:644-649 (1989).
Apostolopoulos et al., Production of Anti-breast Cancer Monoclonal Antibodies Using a Glutathione-S-Transferase-MUC1 Bacterial Fusion Protein, British J. Cancer 67:713-720, 1993.
Fontenot et al., Biophysical Characterization of One-, Two-, and Three-Tandem Repeats of Human Mucin (muc-1) Protein Core, Cancer Research 53:5386-5394, 1993.
Kotera et al., Humoral Immunity Against a Tandem Repeat Epitope of Human Mucin MUC-1 in Ser from Breast, Pancreatic, and Colon Cancer Patients, Cancer Research 54:2856-2860, 1994.
Price et al., Immunological and Structural Features of the Protein Core of Human Polymorphic Epithelial Mucin, Molecular Immunology 27:795-802, 1990.
Xing et al., Monoclonal Antibodies Reactive with Mucin Expressed in Breast Cancer, Immunol. Cell Biol. 67:183-195 1989.
Xing et al., Effect of Variations in Peptide Sequence on Anti-Human Milk Fat Globule Membrane Antibody Reactions, Immunology 72:304-311, 1991.
Xing et al., Second Generation Anti-MUC1 Peptide Monoclonal Antibodies, Cancer Research 52:2310-2317, 1992.
Xing et al., Epitope Mapping of Anti-Breast and Anti-Ovarian Mucin Monoclonal Antibodies, Molecular Immunology 29:641-650, 1992.
Abe, et al., Identification Of A Family Of High Molecular Weight Tumor-Associated Glycoproteins, J. Immunol. 139:257-261, 1987.
Abe, et al., Structural Analysis Of The DF3 Human Breast Carcinoma-Associated Protein, Cancer Res., 49:2834-2839, 1989.
Arklie, et al., Differentiation Antigens Expressed By Epithelial Cells in the Lactating Breast Are Also Detectable In Breast Cancers, Int. J. Cancer 28:23-29, 1981.
Bird, et al., Single-Chain Antigen-Binding Proteins, Science, 242:423-426, 1988.
Burchell, et al., A Short Sequence, Within The Amino Acid Tandem Repeat Of A Cancer-Associated Mucin, Contains Immunodominant Epitopes, Int. J. Cancer 44:691-696, 1989.
Burchell, et al., Development And Characterization Of Breast Cancer Reactive Monoclonal Antibodies Directed To The Core Protein Of The Human Milk Mucin, Cancer Res. 47:5476-5482, 1987.
Cawley, et al., Epidermal Growth Factor-Toxin A Chain Conjugates: EGF-Ricin A Is A Potent Toxin While EGF-Diphtheria Fragment A Is Nontoxic, Cell 22:563-570, 1980 (Part 2).
Chang, et al., Artificial Hybrid Protein Containing A Toxic Protein Fragment And A Cell Membrane Receptor-Binding Moiety In A Disulfide Conjugate, J. Biol. Chem. 252:1515-1522, 1977.
Chaudhary, et al., Activity Of A Recombinant Fusion Protein Between Transforming Growth Factor Type .alpha. and Pseudomonas Toxin, Proc. Natl. Acad. Sci. USA 84:4538-4542, 1987.
Croghan, et al., Tissue Distribution Of An Epithelial And Tumor-Associated Antigen Recognized By Monoclonal Antibody F36/22, Cancer Res. 43:4980-4988, 1983.
Hayes, et al., Genetically Determined Polymorphism Of The Circulating Human Breast Cancer-Associated DF3 Antigen, Blood 71:436-440, 1988.
Hayes, et al., Comparison Of Circulating CA15-3 And Carcinoembryonic Antigen Levels In Patients With Breast Cancer, J. Clin. Oncol. 4:1542-1550, 1986.
Hilkens, et al., Biosynthesis of MAM-6, An Epithelial Sialomucin, J. Biol. Chem. 263:4215-4222, 1988.
Hilkens, et al., Monoclonal Antibodies Against Human Milk-Fat Globule Membranes Detecting Differentiation Antigens Of The Mammary Gland And Its Tumors, Int. J. Cancer 34:197-206, 1984.
Hilkens, et al., Complexity of MAM-6, An Epithelial Sialomucin Associated With Carcinomas, Cancer Res. 49:786-793, 1989.
Hull, et al., Oligosaccharide Differences In The DF3 Sialomucin Antigen From Normal Human Milk And The BT-20 Human Breast Carcinomas Cell Line, Cancer Commun. 1:261-267, 1989.
Karlsson, et al., A Genetic Polymorphism Of A Human Urinary Mucin, Ann. Hum. Genet. 47:263, 1983.
Kufe, et al., Differential Reactivity Of A Novel Monoclonal Antibody (DF3) With Human Malignant Versus Versus Benign Breast Tumors, Hybridoma, 3:223-232, 1984.
Lundy, et al., Monoclonal Antibody DF3 Correlates With Tumor Differentiation And Hormone Receptor Status In Breast Cancer Patients, Br. Cancer Res. Treat. 5:269-276, 1985.
Sekine, et al., Purification And Characterization Of A High Molecular Weight Glycoprotein Detectable In Human Milk And Breast Carcinomas, J. Immunol. 135:3610-3615, 1985.
Siddiqui, et al., Isolation And Sequencing Of A cDNA Coding For The Human DF3 Breast Carcinoma-Associated Antigen, Proc. Natl. Acad. Sci. USA 85:2320-2323, 1988.
Sloan, et al., Distribution Of Epithelial Membrane Antigen In Normal And Neoplastic Tissues And Its Value In Diagnostic Tumor Pathology, Cancer 47:1786-1795, 1981.
Swallow, et al., The Human Tumour-Associated Epithelial Mucins Are Coded By An Expressed Hypervariable Gene Locus PUM, Nature 328:82-84, 1987.
Tondini, et al., Comparison of CA15-3 And Carcinoembryonic Antigen In Monitoring The Clinical Course Of Patients With Metastatic Breast Cancer, 48:4107-4122, 1988.
Xing et al., Synthetic Peptides Reactive with Anti-Human Mil Fat Globule Membrane Monoclonal Antibodies, Cancer Research 50:89-96, 1990.
Harris et al., Therapeutic Antibodies--The Coming of Age, TIBTECH 11:42-46, 1993.
Dana-Farber Cancer Institute Inc.
Gambel Phillip
Parr Margaret
LandOfFree
Antibodies specific for the DF3 carcinoma associated antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies specific for the DF3 carcinoma associated antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies specific for the DF3 carcinoma associated antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-140154